Compound Fights Gleevec-Resistant Leukemia
520231
MONDAY, Feb. 14 (HealthDay News) -- The drug Gleevec has proven a lifesaver for people with a blood cancer called chronic myeloid leukemia (CML). However, a growing number of CML patients have cancers resistant to the medication.
518874
WEDNESDAY, Sept. 29 (HealthDayNews) -- The anti-cancer drug Gleevec, highly touted for slowing the progression of chronic myeloid leukemia, also appears to stall a rare kind of skin cancer, a new study finds.
485506
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells. The Food and Drug Administration approved the drug, Zolinza, to treat advanced cases of cutaneous T-cell lymphoma, a rare cancer that's a form of non-Hodgkin's lymphoma. Roughly 20,000 Americans have the cancer, Merck said.
621058
About half of the patients in the US with aggressive non-Hodgkin&#39;s lymphoma, (NHL), cancer of the lymph glands, are not receiving the full dose of chemotherapy that
757229
Genzyme Corp. of Cambridge and German partner Bayer Schering Pharma AG said they have begun phase 3 trials of their cancer drug Campath to treat multiple sclerosis. The companies said they plan on reporting phase 2 results Oct. 14. After phase 3, they hope to seek US regulatory approval in 2011 to market the drug, also known as alemtuzumab, to ...
126276
A drug already used to treat kidney cancer became the first medicine to extend the life of patients with advanced liver cancer in a clinical trial, adding about three months to survival compared to a placebo, according to a study released on Monday.
350952
Next-generation leukemia pills,  designed to help patients not cured by the successful drug  Gleevec, work even better than doctors had hoped, researchers  said on Sunday.
372129
A successful cancer-fighting drug may also damage the heart, although a researcher says leukemia patients who need Gleevec should not abandon it.
131156
LONDON (CBS.MW) -- The US Food and Drug Administration has approved a Genzyme Corp. (GENZ) cancer drug for treating a type of childhood leukemia after other therapies have failed.
1957
A drug currently used to treat kidney cancer has shown promising results in treating the most common and deadly form of adult leukemia, according to a US study released Tuesday.
560148
The Food and Drug Administration approved Clolar, Genzyme Corp.&#39;s new drug for patients under 21 with acute lymphocytic leukemia.
667099
Government scientists turned regular blood cells into tumor attackers that wiped out all signs of cancer in two men with advanced melanoma. The striking finding, unveiled Thursday, marks an important step in the quest for gene therapy for cancer.
636079
New data presented today confirm that advanced lung cancer patients canlook forward to better-quality survival when treated with Alimta(R)(pemetrexed), a newly approved anticancer agent in the European Unioncompared with Taxotere(R) (docetaxel).
357627
A top compound in development could become an important MS treatment.
494329
Leukemia patients who do not respond to the new drug Gleevec are holding out hope for two new experimental drugs that may be able to help.
755755
JACKSONVILLE, FL -- The Food and Drug Administration is giving hope to children with Leukemia that don&#39;t respond to traditional treatments.
243349
This lung cancer drug is not as effective as once hoped.